Dementia & Neurodegenerative Diseases

This feed focuses on the impact of insulin resistance, caloric restriction, cytokine singling, and metabolism on dementia and neurodegenerative diseases. Here is the latest research in this domain.

August 12, 2020

Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration

Journal of Neuroinflammation
Ione O C WoollacottTammaryn Lashley
August 12, 2020
Review

Synergy between amyloid-β and tau in Alzheimer's disease

Nature Neuroscience
Marc Aurel Busche, Bradley T Hyman
August 11, 2020
Review
Open Access

The impact of ATP-binding cassette transporters on metabolic diseases

Nutrition & Metabolism
Zixiang YeTao Wu
August 10, 2020
Open Access

Volumetric GWAS of medial temporal lobe structures identifies an ERC1 locus using ADNI high-resolution T2-weighted MRI data

Neurobiology of Aging
Shan CongAlzheimer’s Disease Neuroimaging Initiative
August 9, 2020
Open Access

Shexiang Baoxin Pill, a Traditional Chinese Herbal Formula, Rescues the Cognitive Impairments in APP/PS1 Transgenic Mice

Frontiers in Pharmacology
Wei-Hui HuKarl Wah-Keung Tsim
August 9, 2020

Topological Network Analysis of Early Alzheimer's Disease Based on Resting-State EEG

IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society
Feng DuanJordi Sole-Casals
August 12, 2020

Comparing progression biomarkers in clinical trials of early Alzheimer's disease

Annals of Clinical and Translational Neurology
Nicholas C CullenNiklas Mattsson-Carlgren
August 12, 2020

The Mexican Cognitive Aging Ancillary Study (Mex-Cog): Study Design and Methods

Archives of Gerontology and Geriatrics
Silvia Mejia-ArangoRebeca Wong
August 9, 2020

Correlation of Alzheimer's Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Ivan KoychevNicholas C Friedman
August 11, 2020
Open Access

Classifying dementia progression using microbial profiling of saliva

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Praveen BathiniLavinia Auber Alberi
August 10, 2020

Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration

Journal of Neurology, Neurosurgery, and Psychiatry
Tamara Paulo TavaresElizabeth Finger
August 11, 2020

Anti-Amyloid-β Protein agents for the treatment of Alzheimer's Disease: An update on emerging drugs

Expert Opinion on Emerging Drugs
Madia LozuponeFrancesco Panza
August 11, 2020
Open Access

Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementia

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Jet M J VonkMEMENTO cohort Study Group
August 11, 2020
Open Access

Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial

Evidence-based Complementary and Alternative Medicine : ECAM
Huiqin ZhangHao Li
August 11, 2020

Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment

Journal of the International Neuropsychological Society : JINS
Nicholas I BradfieldDavid Ames

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/dementia-neurodegenerative-diseases/d57ab6a4-aabc-444f-9d59-10f4318bed7a